Spanish MDS study reveals Real-World treatment trends
NCT ID NCT07465029
First seen Mar 18, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This study looks at medical records from about 1,300 adults in Spain with a type of blood cancer called lower-risk myelodysplastic syndromes (MDS) that requires regular blood transfusions. Researchers want to find out how common this condition is, which treatments doctors use first, and how patients fare over time. The goal is to better understand real-world care and improve future treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER-RISK MYELODYSPLASTIC SYNDROMES (TD LR-MDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Madrid, 28001, Spain
Conditions
Explore the condition pages connected to this study.